(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1630949

米国の末梢血管装置・付属品市場：市場規模・シェア・動向分析 (製品別・用途別・最終用途別・セグメント別、2025年～2030年)

U.S. Peripheral Vascular Devices And Accessories Market Size, Share & Trends Analysis Report By Product (Peripheral Stents, PTA Balloons), By Application (Peripheral Arterial Disease, Aneurysms), By End-use, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
米国の末梢血管装置・付属品市場：市場規模・シェア・動向分析 (製品別・用途別・最終用途別・セグメント別、2025年～2030年)
出版日: 2024年12月03日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の末梢血管装置・付属品市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の末梢血管装置・付属品の市場規模は2030年までに49億米ドルに達する見込みです。

同市場は、2025年から2030年にかけてCAGR 5.5%で拡大すると予測されています。静脈疾患または慢性静脈不全 (CVI) の有病率の増加は、市場の成長を促進する主な要因の1つです。さらに、高齢者人口の増加、低侵襲血管内治療に対する需要の増加が、その採用をさらに増加させ、予測期間中の収益成長を後押ししています。

製品種類別では、末梢血管ステントのセグメントが2019年の市場を独占しました。需要増加の要因には、ステント技術の技術的進歩、低侵襲処置の需要増加などがあります。さらに、末梢ステント市場は、即時ステント留置を必要とする患者数の増加、末梢血管インターベンションの技術革新、政府イニシアチブの増加などが主な要因となっています。これらの要因が全体の成長をさらに後押ししています。

米国の末梢血管装置・付属品市場：分析概要

  • 末梢ステント分野は2024年に20.4%の最大市場シェアを占め、予測期間中に最も速いCAGRで成長すると予測されます。
  • 2024年、末梢動脈疾患 (PAD) が45.5%の最大市場シェアを占めました。末梢動脈疾患が市場を独占したのは、この疾患の有病率の増加が介入への需要の高まりにつながっているためです。
  • 病院セグメントは2024年に64.2%のシェアで市場を独占しました。病院は大量の患者を治療できるため、血管器具・付属品市場を独占しています。
  • 外来手術センターセグメントは予測期間中に大きく成長する見込みです。外来手術センター (ASC) は、主に外来治療の増加傾向により、末梢血管機器市場の主要なプロバイダーとなっています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 米国の末梢血管装置・付属品市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 米国の末梢血管アクセス装置・付属品市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析
    • パイプライン分析

第4章 米国の末梢血管装置・付属品市場：製品別の推定と動向分析

  • 米国の末梢血管装置・付属品市場：製品別のダッシュボード
  • 米国の末梢血管装置・付属品市場：製品別の変動分析
  • 米国の末梢血管装置・付属品市場：市場規模の予測と動向分析、製品別 (収益ベース、2018～2030年)
  • 末梢ステント
    • 腸骨動脈ステント
    • 大腿動脈ステント
    • 頸動脈ステント
    • 腎動脈ステント
    • その他
  • PTAバルーン
  • カテーテル
    • 血管造影カテーテル
    • ガイドカテーテル
    • IVUS/OCTカテーテル
  • 血管内動脈瘤修復ステントグラフト
    • 胸部血管内動脈瘤ステントグラフト
    • 腹部血管内動脈瘤ステントグラフト
  • プラーク修正装置
    • アテローム切除装置
    • 血栓除去装置
  • 周辺機器アクセサリ
    • ガイドワイヤー
    • 末梢血管閉鎖デバイス
    • バルーン膨張装置
    • イントロデューサーシース
  • 下大静脈フィルター
    • 常置型フィルター
    • 着脱型フィルター
  • 血行動態・血流変更装置
    • 慢性完全閉塞デバイス
    • 塞栓保護デバイス

第5章 米国の末梢血管装置・付属品市場：用途別の推定と動向分析

  • 米国の末梢血管装置・付属品市場：用途別のダッシュボード
  • 米国の末梢血管装置・付属品市場：用途別の変動分析
  • 米国の末梢血管装置・付属品市場：市場規模の予測と動向分析、用途別 (収益ベース、2018～2030年)
  • 末梢動脈疾患 (PAD)
  • 動脈瘤
  • 静脈疾患
  • その他

第6章 米国の末梢血管装置・付属品市場：最終用途別の推定と動向分析

  • 米国の末梢血管装置・付属品市場：最終用途別のダッシュボード
  • 米国の末梢血管装置・付属品市場：最終用途別の変動分析
  • 米国の末梢血管装置・付属品市場：市場規模の予測と動向分析、最終用途別 (収益ベース、2018～2030年)
  • 病院
  • 外来手術センター
  • その他

第7章 競合情勢

  • 最新動向と影響分析：主要メーカー別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析 (2024年)
  • 企業プロファイル
    • Abbott
    • Terumo Medical Corporation
    • Medtronic
    • Boston Scientific Corporation
    • Cordis
    • Koninklijke Philips NV
    • AngioDynamics, Inc.
    • Asahi Intecc Co. Ltd.
    • BD
    • BIOTRONIK SE &Co. KG
    • Biosensors International Group Ltd.
    • B. Braun SE
    • iVascular
    • Merit Medical Systems, Inc.
    • Cook Group Inc
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. peripheral vascular devices and accessories market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. peripheral vascular devices and accessories market, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. peripheral vascular devices and accessories market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 U.S. peripheral vascular devices and accessories market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 U.S. peripheral vascular devices and accessories market: Product Outlook Key Takeaways
  • Fig. 15 U.S. peripheral vascular devices and accessories market: Product Movement Analysis
  • Fig. 16 Peripheral stents market, 2018 - 2030 (USD Million)
  • Fig. 17 Iliac artery stents market, 2018 - 2030 (USD Million)
  • Fig. 18 Femoral artery stents market, 2018 - 2030 (USD Million)
  • Fig. 19 Carotid artery Stents market, 2018 - 2030 (USD Million)
  • Fig. 20 Renal artery Stents market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 PTA balloons market, 2018 - 2030 (USD Million)
  • Fig. 23 Catheters market, 2018 - 2030 (USD Million)
  • Fig. 24 Angiography catheters market, 2018 - 2030 (USD Million)
  • Fig. 25 Guiding catheters market, 2018 - 2030 (USD Million)
  • Fig. 26 IVUS/OCT catheters market, 2018 - 2030 (USD Million)
  • Fig. 27 Endovascular aneurysm repair stent grafts market, 2018 - 2030 (USD Million)
  • Fig. 28 Thoracic endovascular aneurysm stent grafts market, 2018 - 2030 (USD Million)
  • Fig. 29 Abdominal endovascular aneurysm stent grafts market, 2018 - 2030 (USD Million)
  • Fig. 30 Plaque modification devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Atherectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Thrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Peripheral accessories market, 2018 - 2030 (USD Million)
  • Fig. 34 Guidewires market, 2018 - 2030 (USD Million)
  • Fig. 35 Workhorse guidewires market, 2018 - 2030 (USD Million)
  • Fig. 36 Specialty guidewires market, 2018 - 2030 (USD Million)
  • Fig. 37 Extra support guidewires market, 2018 - 2030 (USD Million)
  • Fig. 38 Frontline finesse guidewires market, 2018 - 2030 (USD Million)
  • Fig. 39 Peripheral vascular closure devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Balloon inflation devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Introducer sheaths market, 2018 - 2030 (USD Million)
  • Fig. 42 Inferior vena cava filters market, 2018 - 2030 (USD Million)
  • Fig. 43 Permanent filters market, 2018 - 2030 (USD Million)
  • Fig. 44 Retrievable filters market, 2018 - 2030 (USD Million)
  • Fig. 45 Hemodynamic flow alteration devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Chronic total occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Embolic protection devices market, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. peripheral vascular devices and accessories market: Application outlook key takeaways
  • Fig. 49 U.S. peripheral vascular devices and accessories market: Application movement analysis
  • Fig. 50 Peripheral arterial disease (PAD) Market, 2018 - 2030 (USD Million)
  • Fig. 51 Aneurysms market, 2018 - 2030 (USD Million)
  • Fig. 52 Venous diseases market, 2018 - 2030 (USD Million)
  • Fig. 53 Others market, 2018 - 2030 (USD Million)
  • Fig. 54 U.S. peripheral vascular devices and accessories market: End use outlook key takeaways
  • Fig. 55 U.S. peripheral vascular devices and accessories market: End use movement analysis
  • Fig. 56 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 57 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 58 Others market, 2018 - 2030 (USD Million)
  • Fig. 59 Strategy framework
目次
Product Code: GVR-4-68039-243-5

U.S. Peripheral Vascular Devices And Accessories Market Growth & Trends:

The U.S. peripheral vascular devices and accessories market size is expected to reach USD 4.9 billion by 2030, according to a new report by Grand View Research, Inc. The market and is expected to expand at a CAGR of 5.5% from 2025 to 2030. Growing prevalence of venous diseases or Chronic Venous Insufficiency (CVI) is one of the key factors driving the growth of the market. Furthermore, growing geriatric population, and increasing demand for minimally invasive endovascular procedures is further increasing its adoption and bolstering revenue growth over the forecast period.

Based on product type, the peripheral vascular stents segment dominated the market in 2019. Factors contributing to the increase in demand include technological advancements in stent technology and increasing demand for minimally invasive procedures. In addition, the peripheral stent market is majorly driven by a growing patient pool requiring the immediate stent placement, technological innovations in peripheral vascular interventions, and growing number of government initiatives. These factors are further propelling the overall growth.

U.S. Peripheral Vascular Devices And Accessories Market Report Highlights:

  • The peripheral stents segment held the largest market share of 20.4% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period
  • In 2024, peripheral arterial disease (PAD) held the largest market share of 45.5%. Peripheral arterial disease dominated the market due to the increasing prevalence of this condition leads to higher demand for interventions
  • The hospital segment dominated the market with a share of 64.2% in 2024. Hospitals dominate the vascular devices and accessories market because they can treat a high volume of patients
  • The ambulatory surgical centers segment is expected to grow significantly during the forecast period. Ambulatory surgical centers (ASCs) have become a key provider in the peripheral vascular devices market, primarily due to the growing trend of outpatient care

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Vascular Devices And Accessories Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of vascular diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Minimally invasive treatment preference
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High treatment costs
      • 3.2.2.2. Regulatory and approval challenges
  • 3.3. U.S. Peripheral Vascular Access Devices and Accessories Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. U.S. Peripheral Vascular Devices And Accessories Market: Product Estimates & Trend Analysis

  • 4.1. U.S. Peripheral Vascular Devices And Accessories Market: Product Dashboard
  • 4.2. U.S. Peripheral Vascular Devices And Accessories Market: Product Movement Analysis
  • 4.3. U.S. Peripheral Vascular Devices And Accessories Market by Product, Revenue
  • 4.4. Peripheral Stents
    • 4.4.1. Peripheral stents market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Iliac artery stents
      • 4.4.2.1. Iliac artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Femoral artery stents
      • 4.4.3.1. Femoral artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Carotid artery stents
      • 4.4.4.1. Carotid artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.5. Renal artery stents
      • 4.4.5.1. Renal artery stents market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. PTA Balloons
    • 4.5.1. PTA balloons market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. Catheters
    • 4.6.1. Catheters market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.2. Angiography catheters
      • 4.6.2.1. Angiography catheters market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.3. Guiding catheters
      • 4.6.3.1. Guiding catheters market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.4. IVUS/OCT Catheters
      • 4.6.4.1. IVUS/OCT catheters market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Endovascular Aneurysm Repair Stent Grafts
    • 4.7.1. Endovascular aneurysm repair stent grafts market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.7.2. Thoracic endovascular aneurysm stent grafts
      • 4.7.2.1. Thoracic endovascular aneurysm stent grafts market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.7.3. Abdominal endovascular aneurysm stent grafts
      • 4.7.3.1. Abdominal endovascular aneurysm stent grafts market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.8. Plaque Modification Devices
    • 4.8.1. Plaque modification devices market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.8.2. Atherectomy devices
      • 4.8.2.1. Atherectomy devices market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.8.3. Thrombectomy devices
      • 4.8.3.1. Thrombectomy devices market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.9. Peripheral Accessories
    • 4.9.1. Peripheral accessories market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.9.2. Guidewires
      • 4.9.2.1. Guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.9.2.2. Workhorse guidewires
        • 4.9.2.2.1. Workhorse guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.9.2.3. Specialty guidewires
        • 4.9.2.3.1. Specialty guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.9.2.4. Extra support guidewires
        • 4.9.2.4.1. Extra support guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.9.2.5. Frontline finesse guidewires
        • 4.9.2.5.1. Frontline finesse guidewires market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.9.3. Peripheral vascular closure devices
      • 4.9.3.1. Peripheral vascular closure devices market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.9.4. Balloon inflation devices
      • 4.9.4.1. Balloon inflation devices market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.9.5. Introducer sheaths
      • 4.9.5.1. Introducer sheaths market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.10. Inferior vena cava filters
    • 4.10.1. Inferior vena cava filters market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.10.2. Permanent filters
      • 4.10.2.1. Permanent filters market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.10.3. Retrievable filters
      • 4.10.3.1. Retrievable filters market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.11. Hemodynamic flow alteration devices
    • 4.11.1. Hemodynamic flow alteration devices market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.11.2. Chronic total occlusion devices
      • 4.11.2.1. Chronic total occlusion devices market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.11.3. Embolic protection devices
      • 4.11.3.1. Embolic protection devices market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Peripheral Vascular Devices And Accessories Market: Application Estimates & Trend Analysis

  • 5.1. U.S. Peripheral Vascular Devices And Accessories Market: Application Dashboard
  • 5.2. U.S. Peripheral Vascular Devices And Accessories Market: Application Movement Analysis
  • 5.3. U.S. Peripheral Vascular Devices And Accessories Market by Application, Revenue
  • 5.4. Peripheral Arterial Disease (PAD)
    • 5.4.1. Peripheral Arterial Disease (PAD) market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Aneurysms
    • 5.5.1. Aneurysms market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Venous Diseases
    • 5.6.1. Venous diseases market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Peripheral Vascular Devices And Accessories Market: End-use Estimates & Trend Analysis

  • 6.1. U.S. Peripheral Vascular Devices And Accessories Market: End Use Dashboard
  • 6.2. U.S. Peripheral Vascular Devices And Accessories Market: End Use Movement Analysis
  • 6.3. U.S. Peripheral Vascular Devices And Accessories Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Terumo Medical Corporation
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Medtronic
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Boston Scientific Corporation
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Cordis
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Koninklijke Philips N.V.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. AngioDynamics, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Asahi Intecc Co. Ltd.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. BD
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. BIOTRONIK SE & Co. KG
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Biosensors International Group Ltd.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. B. Braun SE
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. iVascular
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. Merit Medical Systems, Inc.
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. Cook Group Inc
      • 7.4.15.1. Company overview
      • 7.4.15.2. Financial performance
      • 7.4.15.3. Product benchmarking
      • 7.4.15.4. Strategic initiatives